Science
Mechanism of Action
This potent oligopeptide primarily operates by stimulating the proliferation of epidermal cells, thereby accelerating cell growth, division, and differentiation within the skin's epithelial layers. This action promotes rapid skin renewal and repair processes. Concurrently, S-SILKWORM OLIGOPEPTIDE-1 SP boosts the synthesis of crucial structural proteins like collagen and elastin, contributing to enhanced skin firmness and elasticity. It also increases hyaluronic acid production for sustained, long-term hydration, aids in wound healing, mitigates hyperpigmentation, combats blemishes through anti-inflammatory pathways, strengthens the skin barrier, and may assist in regulating sebum production to reduce acne lesions.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
S-SILKWORM OLIGOPEPTIDE-1 SP has not undergone specific safety assessment by major regulatory bodies such as CIR, SCCS, or FDA. While generic SH-Oligopeptide-1 (EGF) is authorized as a cosmetic ingredient, its long-term risks are largely unexplored. Some sources indicate that active EGF might be considered an unauthorized drug rather than a cosmetic. Although EGF is mitogenic (stimulates cell proliferation), it is not deemed mutagenic (cancer-causing) for individuals without pre-existing cancer. Clinical studies for sh-oligopeptide-1 have been cited as lacking scientific basis, with unproven preclinical bioactivity, leading to uncertainty regarding overall safety for this specific form.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While S-SILKWORM OLIGOPEPTIDE-1 SP presents a promising mechanistic profile for comprehensive skin regeneration and repair, the absence of specific safety assessments and robust clinical data for this particular ingredient necessitates a cautious and questionable rating for general cosmetic applications.
Related
Similar Ingredients
Finding similar ingredients…